Metagenomi, Inc. Common Stock (MGX) stock news · rev $25.2M
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
This MGX news page leads with what Metagenomi, Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for MGX yet. We will not pad this page with generic market recap.
Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MGX stock page; for the tape open the quote page.
MGX stock news FAQ
What are MGX's latest revenue and net income?
Latest cached Metagenomi, Inc. Common Stock (MGX) revenue for Dec 31, 2025 was $25.2M. Net income was -$87.9M. Statements: https://lician.com/financials/mgx
How did MGX revenue change from the prior cached period?
Cached Metagenomi, Inc. Common Stock (MGX) revenue was down 51.8% from $52.3M (Dec 31, 2024) to $25.2M (Dec 31, 2025). Statements: https://lician.com/financials/mgx
What is MGX's market cap?
Metagenomi, Inc. Common Stock (MGX) market cap is $44.4M on the latest cached fundamentals snapshot.
What kind of company is MGX?
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
Where is MGX stock news listed?
Cached stock news for Metagenomi, Inc. Common Stock (MGX) is listed at https://lician.com/news/mgx. Filings: https://lician.com/sec/mgx
Not investment advice.